These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25119986)

  • 1. Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting.
    Kwon T; Jeong IG; Lee J; Lee C; You D; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):169-76. PubMed ID: 25119986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
    Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
    JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
    Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
    Int J Clin Oncol; 2007 Apr; 12(2):131-6. PubMed ID: 17443281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification.
    Sakura Y; Yamashita R; Notsu A; Usui K; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
    Int J Urol; 2024 Jul; 31(7):785-792. PubMed ID: 38606834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J
    BMC Cancer; 2019 Jul; 19(1):716. PubMed ID: 31324162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.
    Pak S; You D; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Kim CS; Ahn H
    Sci Rep; 2019 Jun; 9(1):8305. PubMed ID: 31165753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
    Rink M; Hansen J; Cha EK; Green DA; Babjuk M; Svatek RS; Xylinas E; Tagawa ST; Faison T; Novara G; Karakiewicz PI; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Comploj E; Tilki D; Bastian PJ; Chun FK; Dahlem R; Scherr DS; Shariat SF
    BJU Int; 2013 Jan; 111(1):74-84. PubMed ID: 22809039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
    Lucca I; Rouprêt M; Kluth L; Rink M; Tilki D; Fajkovic H; Kassouf W; Hofbauer SL; de Martino M; Karakiewicz PI; Briganti A; Trinh QD; Seitz C; Fritsche HM; Burger M; Lotan Y; Kramer G; Shariat SF; Klatte T
    BJU Int; 2015 May; 115(5):722-7. PubMed ID: 24905084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival.
    Grunewald CM; Henn A; Galsky MD; Plimack ER; Harshman LC; Yu EY; Crabb SJ; Pal SK; Alva AS; Powles T; De Giorgi U; Agarwal N; Bamias A; Ladoire S; Necchi A; Vaishampayan UN; Sternberg CN; Bellmunt J; Baniel J; Niegisch G
    Urol Oncol; 2020 Dec; 38(12):934.e1-934.e9. PubMed ID: 32660788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients.
    Zhang ZL; Dong P; Li YH; Liu ZW; Yao K; Han H; Qin ZK; Zhou FJ
    Chin J Cancer; 2014 Mar; 33(3):165-71. PubMed ID: 23958053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort.
    Pouessel D; Bastuji-Garin S; Houédé N; Vordos D; Loriot Y; Chevreau C; Sevin E; Beuzeboc P; Taille A; Le Thuaut A; Allory Y; Culine S
    Clin Genitourin Cancer; 2017 Feb; 15(1):e45-e52. PubMed ID: 27554584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
    Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG
    Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer.
    Park E; Ha HK; Chung MK
    Int Urol Nephrol; 2011 Dec; 43(4):1059-65. PubMed ID: 21626133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
    Guzzo TJ; Resnick MJ; Canter DJ; Balandra A; Bergey MR; Magerfleisch L; Tomaszewski JE; Vaughn DJ; Malkowicz SB
    Can J Urol; 2010 Dec; 17(6):5465-71. PubMed ID: 21172112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer.
    Kanatani A; Nakagawa T; Kawai T; Naito A; Sato Y; Yoshida K; Nozaki K; Nagata M; Yamada Y; Azuma T; Suzuki M; Fujimura T; Fukuhara H; Nishimatsu H; Kume H; Igawa Y; Homma Y
    Clin Genitourin Cancer; 2015 Apr; 13(2):e107-12. PubMed ID: 25456839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.
    Soloway MS; Lopez AE; Patel J; Lu Y
    Cancer; 1994 Apr; 73(7):1926-31. PubMed ID: 8137219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
    Zlotta AR; Ballas LK; Niemierko A; Lajkosz K; Kuk C; Miranda G; Drumm M; Mari A; Thio E; Fleshner NE; Kulkarni GS; Jewett MAS; Bristow RG; Catton C; Berlin A; Sridhar SS; Schuckman A; Feldman AS; Wszolek M; Dahl DM; Lee RJ; Saylor PJ; Michaelson MD; Miyamoto DT; Zietman A; Shipley W; Chung P; Daneshmand S; Efstathiou JA
    Lancet Oncol; 2023 Jun; 24(6):669-681. PubMed ID: 37187202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.